Fact Check: Nevada Did NOT 'Quietly Reverse' Its Decision To 'Block' Hydroxychloroquine Prescriptions For COVID-19

Fact Check

  • by: Dana Ford
Fact Check: Nevada Did NOT 'Quietly Reverse' Its Decision To 'Block' Hydroxychloroquine Prescriptions For COVID-19 Order Expired

Did Nevada 'quietly reverse' its decision to 'block' hydroxychloroquine prescriptions for COVID-19? No, that's not true: The emergency regulation simply expired. Also, although the order did put some limits on hydroxychloroquine, it did not prohibit prescriptions of the drug outright. It remained available to COVID-19 patients in hospitals and emergency rooms in Nevada.

The claim appeared in a post (archived here) on Instagram on September 19, 2020. Text alongside the post read: "Bravo Nevada. Anyone else waking up?" The post opened:

Nevada is now the 7th state to quietly reverse their decision to block HCQ prescriptions for COVID-19. Physicians in Nevada can now once again prescribe HCQ as they deem necessary.

This is what users saw on social media:

View this post on Instagram

Bravo Nevada. Anyone else waking up?

A post shared by Dr. Sherri Tenpenny (@drtenpenny) on

Back in March, Nevada Gov. Steve Sisolak signed an emergency order that limited the prescribing and dispensing of hydroxychloroquine and chloroquine. The two drugs, which are approved to treat malaria and autoimmune diseases, were being touted by some -- most notably, by President Donald Trump -- as useful in the prevention and treatment COVID-19. Since then, most studies have shown that the drugs' risks outweigh their benefits. In fact, after granting emergency use authorization early in the pandemic, the U.S. Food and Drug Administration revoked its authorization.

The stated goal of the regulation in Nevada was to prevent hoarding. Here's what Sisolak said at the time:

He later stressed that the order exempted hospitals and emergency rooms, tweeting:

According to the Nevada State Board of Pharmacy, the regulation expired on July 21, 2020. Although it is no longer in effect, the order was not "quietly reversed," as the post alleges. Nor, even when it was in effect, did the regulation block hydroxychloroquine prescriptions for COVID-19 patients.

Lead Stories reached out to the governor's office as well as the Nevada State Board of Pharmacy for comment. We will update this story, as necessary, if they respond.

The Instagram post containing the claim is a copy of a tweet published by Simone Gold, founder of America's Frontline Doctors, a pro-hydroxychloroquine and anti-mask group that Lead Stories debunked when Gold falsely claimed they had a cure for COVID-19.

MedPageToday fact-checked the opening press conference of America's Frontline Doctors by pointing out that none of the 10 doctors speaking for the group are involved in medical specialties that would treat COVID-19 cases and some are no longer practicing medicine.

Want to inform others about the accuracy of this story?

See who is sharing it (it might even be your friends...) and leave the link in the comments.:

Lead Stories is working with the CoronaVirusFacts/DatosCoronaVirus Alliance, a coalition of more than 100 fact-checkers who are fighting misinformation related to the COVID-19 pandemic. Learn more about the alliance here.

  Dana Ford

Dana Ford is an Atlanta-based reporter and editor. She previously worked as a senior editor at Atlanta Magazine Custom Media and as a writer/ editor for CNN Digital. Ford has more than a decade of news experience, including several years spent working in Latin America.

Read more about or contact Dana Ford

About Us

International Fact-Checking Organization Meta Third-Party Fact Checker

Lead Stories is a fact checking website that is always looking for the latest false, misleading, deceptive or inaccurate stories, videos or images going viral on the internet.
Spotted something? Let us know!.

Lead Stories is a:


Subscribe to our newsletter

* indicates required

Please select all the ways you would like to hear from Lead Stories LLC:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Most Read

Most Recent

Share your opinion